Some observations upon biochemical causes of ataxia and a new disease entity ubiquinone, CoQ10 deficiency

Neurochemical Research

Volumn 32, Issue 4-5, 2007, Pages 837-843

  Land, John M ^a   Heales, Simon J R ^a   Duncan, Andrew J ^b   Hargreaves, Iain P ^a  

^a NATIONAL HOSPITAL FOR NEUROLOGY AND NEUROSURGERY   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Ataxia; Friedreich; Refsum's disease; Ubiquinone

Indexed keywords

ACYL COENZYME A DEHYDROGENASE; FRATAXIN; OXIDOREDUCTASE; OXOACID; OXOGLUTARATE DEHYDROGENASE; PYRUVATE DECARBOXYLASE; PYRUVATE DEHYDROGENASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE (UBIQUINONE); SUCCINATE DEHYDROGENASE (UBIQUINONE); UBIDECARENONE; UBIQUINOL CYTOCHROME C REDUCTASE; UBIQUINONE;

BIOENERGY; CLINICAL FEATURE; COMPARATIVE STUDY; DISEASE ASSOCIATION; DRUG MEGADOSE; ENCEPHALOMYOPATHY; ENZYME ANALYSIS; ENZYME DEFICIENCY; ENZYME SUBSTRATE; FRIEDREICH ATAXIA; HEREDITARY ATAXIA; HUMAN; MITOCHONDRIAL ENCEPHALOMYOPATHY; MUSCLE BIOPSY; NEUROCHEMISTRY; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN FUNCTION; PYRUVATE DECARBOXYLASE DEFICIENCY; PYRUVATE DEHYDROGENASE DEFICIENCY; REFSUM DISEASE; REVIEW; UBIDECARENONE DEFICIENCY;

ANIMALS; ATAXIA; ENERGY METABOLISM; HUMANS; KETO ACIDS; OXIDATION-REDUCTION; REFSUM DISEASE; UBIQUINONE;

EID: 33947586652     PISSN: 03643190     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11064-006-9222-8     Document Type: Review

References (53)

1. Refsum's Heredopathia actica polyneuritiformis (1946) Acta Psychiatr Scand Suppl 38:9
2. Klenk E, Kahike W (1963) On the presence of 3,7,11,15- tetramethylhexadecanoic acid (phytanic acid) in the cholesterol esters and other fractions of the organs in a case of a disease of unknown origin (possibly heredopathia atactica polyneuritiformis, Refsum's syndrome). Hoppe Seylers Z Physiol Chem 333:133-139
3. Steinberg D, Avigan J, Mize C, Eldjarn L, Try K, Refsum S (1965) Conversion of U-C14-phytol to phytanic acid and its oxidation in heredopathia atactica polyneuritiformis. Biochem Biophys Res Commun 19:783-789
4. Blass JP, Avign J, Steinberg D (1969) Alpha-hydroxy fatty acids in hereditary ataxic polyneuritis (Refsum's disease). Biochim Biophys Acta 29(187):36-41
5. Tsai SC, Avigan J, Steinberg D (1969) Studies on the alpha oxidation of phytanic acid by rat liver mitochondria. J Biol Chem 244:2682-2692
6. Tsai SC, Herndon JH Jr, Uhlendorf BW, Fales HM, Mize CE (1967) The formation of alpha-hydroxy phytanic acid from phytanic acid in mammalian tissues. Biochem Biophys Res Commun 28:571-577
7. Mize CE, Herndon JH Jr, Blass JP, Milne GW, Follansbee C, Laudat P, Steinberg D (1969) Localization of the oxidative defect in phytanic acid degradation in patients with Refsum's disease. J Clin Invest 48:1033-1040
8. Jansen GA, Ofman R, Ferdinandusse S, Ijlst L, Muijsers AO, Skjeldal OH, Stokke O, Jakobs C, Besley GTN, Wraith JE, Wanders RJA (1997) Refsum disease is caused by mutations in the phytanoyl-CoA hydroxylase gene. Nat Genet 17:190-193
9. Garrod AE (1909) Inborn errors of metabolism Oxford University Press. England
10. Eldjarn L, Try K, Stokke O, et al (1966) Dietary effects on serum-phytanic-acid levels and on clinical manifestations in heredopathia atactica polyneuritiformis. Lancet 1:691-693
11. Kark RA, Engel WK, Blass JP, et al (1971) Heredopathia actica polyneuritiformis (Refsum's Disease): a second trial of dietary therapy in two patients. Birth Defects Orig Artic Ser 1:53-55
12. Djupesland G, Flottorp G, Refsum S (1983) Phytanic acid storage disease: hearing maintained after 15 years of dietary treatment. Neurology 33:237-240
13. Blass JP, Avigan J, Uhlendorf BW (1970) A defect in pyruvate decarboxylase in a child with an intermittent movement disorder. J Clin Invest 49:423-432
14. Blass JP, Lonsdale D, Uhlendorf BW, Hom E (1971) Intermittent ataxia with pyruvate-decarboxylase deficiency. Lancet 7712:1302
15. Blass JP, Kark AP, Engel WK (1971) Clinical studies of a patient with pyruvate decarboxylase deficiency. Arch Neurol 25:449-460
16. Reynolds SF, Blass J (1976) A possible mechanism for selective cerebellar damage in partial pyruvate dehydrogenase deficiency. Neurology 26:625-628
17. Letellier T, Heinrich R, Malgat M, Mazat JP (1994) The kinetic basis of threshold effects observed in mitochondrial diseases: a systemic approach. Biochem J 302:171-174
18. Davey GP, Peuchen S, Clark JB (1998) Energy thresholds in brain mitochondria. Potential involvement in neurodegeneration. J Biol Chem 273:12753-12757
19. Cedarbaum JM, Blass JP (1986) Mitochondrial dysfunction and spinocerebellar degenerations. Neurochem Pathol 4:43-63
20. Sheu KF, Blass JP, Cedarbaum JM, et al (1988) Mitochondrial enzymes in hereditary ataxias. Metab Brain Dis 3:151-160
21. Campuzano V, Montermini L, Molto MD, et al (1996) Friedreich's ataxia: autosomal recessive disease caused by an intronic GAA triplet repeat expansion. Science 271:1423-1427
22. Durr A, Cossee M, Agid Y, et al (1996) Clinical and genetic abnormalities in patients with Friedreich's ataxia. N Engl J Med 335:1169-1175
23. Beal MF (1998) Mitochondrial dysfunction in neurodegenerative diseases. Biochim Biophys Acta 1366:211-223
24. Calabrese V, Lodi R, Tonon C, et al (2005) Oxidative stress, mitochondrial dysfunction and cellular stress response in Friedreich's ataxia. J Neurol Sci 233:145-162
25. Pandolfo M (2001) Molecular basis of Friedreich ataxia. Mov Disord 16:815-821
26. Emond M, Lepage G, Vanasse M, Pandolfo M (2000) Increased levels of plasma malondialdehyde in Friedreich ataxia. Neurology 55:1752-1753
27. Rustin P, von Kleist-Retzow JC, Chantrel-Groussard K, et al (1999) Effect of idebenone on cardiomyopathy in Friedreich's ataxia: a preliminary study. Lancet 354:477-479
28. Aure K, Benoist JF, Ogier de Baulny H, Romero NB, Rigal O, Lombes A (2004) Progression despite replacement of a myopathic form of coenzyme Q10 defect. Neurology 63:727-729
29. Artuch R, Aracil A, Mas A, et al (2004) Cerebrospinal fluid concentrations of idebenone in Friedreich ataxia patients. Neuropediatrics 35:95-98
30. Artuch R, Brea-Calvo G, Briones P, et al (2006) Cerebellar ataxia with coenzyme Q10 deficiency: diagnosis and follow-up after coenzyme. J Neurol Sci 246:153-158
31. Turunen M, Olsson J, Dallner G (2004) Metabolism and function of coenzyme Q. Biochim Biophys Acta 1660:171-199
32. Shults CW (2003) Coenzyme Q10 in neurodegenerative diseases. Curr Med Chem 10:1917-1921
33. Linnane AW, Eastwood H (2004) Cellular redox poise modulation; the role of coenzyme Q10, gene and metabolic regulation. Mitochondrion 4:779-789
34. Di Giovanni S, Mirabella M, Spinazzola A, et al (2001) Coenzyme Q10 reverses pathological phenotype and reduces apoptosis in familial CoQ10 deficiency. Neurology 57:515-518
35. Baker SK, Tarnopolsky MA (2003) Targeting cellular energy production in neurological disorders. Expert Opin Investig Drugs 12:1655-1679
36. Kalen A, Appelkvist EL, Chojnacki T, Dallner G (1990) Nonaprenyl-4-hydroxybenzoate transferase, an enzyme involved in ubiquinone biosynthesis, in the endoplasmic reticulum-Golgi system of rat liver. J Biol Chem 265:1158-1164
37. Duncan AJ, Heales SJ, Mills K, Eaton S, Land JM, Hargreaves IP (2005) Determination of coenzyme Q10 status in blood mononuclear cells, skeletal muscle, and plasma by HPLC with di-propoxy-coenzyme Q10 as an internal standard. Clin Chem 51:2380-2382
38. Ernster L, Dallner G (1995) Biochemical, physiological and medical aspects of ubiquinone function. Biochim Biophys Acta 1271:195-204
39. Hirano M, Quinzii CM, Dimauro S (2006) Restoring balance to ataxia with coenzyme Q10 deficiency. J Neurol Sci 246:11-12
40. Fischer JC, Ruitenbeek W, Gabreels FJ, et al (1986) A mitochondrial encephalomyopathy: the first case with an established defect at the level of coenzyme Q. Eur J Pediatr 144:441-444
41. Ogasahara S, Engel AG, Frens D, Mack D (1989) Muscle coenzyme Q deficiency in familial mitochondrial encephalomyopathy. Proc Natl Acad Sci USA 86:2379-2382
42. Lamperti C, Naini A, Hirano M, et al (2003) Cerebellar ataxia and coenzyme Q10 deficiency. Neurology 60:1206-1208
43. Van Maldergem L, Trijbels F, DiMauro S, et al (2002) Coenzyme Q-responsive Leigh's encephalopathy in two sisters. Ann Neurol 52:750-754
44. Rotig A, Appelkvist EL, Geromel V, et al (2000) Quinone-responsive multiple respiratory-chain dysfunction due to widespread coenzyme Q10 deficiency. Lancet 356:391-395
45. Rahman S, Hargreaves I, Clayton P, Heales S (2001) Neonatal presentation of coenzyme Q10 deficiency. J Pediatr 139:456-458
46. Horvath R, Schneiderat P, Schoser BG, et al (2006) Coenzyme Q10 deficiency and isolated myopathy. Neurology 66:253-255
47. Lalani SR, Vladutiu GD, Plunkett K, et al (2005) Isolated mitochondrial myopathy associated with muscle coenzyme Q10 deficiency. Arch Neurol 62:317-320
48. Quinzii CM, Kattah AG, Naini a, et al (2005) Coenzyme Q deficiency and cerebellar ataxia associated with an aprataxin mutation. Neurology 64:539-541
49. Clark JB, Bates TE, Boakye P, Kuimov A, Land JM (1996) Investigation mitochondrial defects in brain and skeletal muscle. In: Turner AJ, Bachelor (eds) In a practical approach to the investigation of metabolic disease. IRL Press at Oxford University Press, Oxford. pp 151-174
50. Davey GP, Peuchen S, Clark JB (1998) Energy thresholds in brain mitochondria. Potential involvement in neurodegeneration. J Biol Chem 273:12753-12757
51. Steele PE, Tang PH, DeGrauw AJ, Miles MV (2004) Clinical laboratory monitoring of coenzyme Q10 use in neurologic and muscular diseases. Am J Clin Pathol 121(Suppl):S113-S120
52. Ullmann U, Metzner J, Schulz C, et al (2005) A new Coenzyme Q10 tablet-grade formulation (all-Q) is bioequivalent to Q-Gel and both have better bioavailability properties than Q-SorB. J Med Food 8:397-399
53. Bhagavan HN, Chopra RK (2006) Coenzyme Q10: absorption, tissue uptake, metabolism and pharmacokinetics. Free Radic Res 40:445-453